We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-1.44%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$40.3B
AUM Growth
-$3.3B
Cap. Flow
-$1.89B
Cap. Flow %
-4.68%
Top 10 Hldgs %
21.18%
Holding
1,160
New
85
Increased
251
Reduced
431
Closed
113

Top Buys

Rank Stock Value
1
AVLR
Avalara, Inc.
AVLR
+$150M
2
EOG icon
EOG Resources
EOG
+$128M
3
TJX icon
TJX Companies
TJX
+$122M
4
RTX icon
RTX Corp
RTX
+$107M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$105M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$365M
2
BURL icon
Burlington
BURL
+$216M
3
TXT icon
Textron
TXT
+$190M
4
DLTR icon
Dollar Tree
DLTR
+$126M
5
XOM icon
ExxonMobil
XOM
+$124M

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Healthcare 17.41%
3 Financials 15.7%
4 Consumer Discretionary 9.78%
5 Industrials 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XP icon
876
XP
XP
$8.62B
$1.36M ﹤0.01%
71,342
-764,553
-91% -$15.2M
JBIO
877
Jade Biosciences
JBIO
$1.35B
$1.33M ﹤0.01%
2,286
-571
-20% -$381K
VIRX
878
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.28M ﹤0.01%
300,000
-170,000
-36% -$720K
SEAT icon
879
Vivid Seats
SEAT
$88.6M
$1.23M ﹤0.01%
+8,000
New +$1.34M
RAIN
880
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$1.21M ﹤0.01%
248,282
+180,000
+264% +$1.13M
GERN icon
881
Geron
GERN
$1.01B
$1.17M ﹤0.01%
+500,000
New +$1.12M
OLMA icon
882
Olema Pharmaceuticals
OLMA
$1.03B
$1.16M ﹤0.01%
420,000
-80,000
-16% -$339K
DNTH icon
883
Dianthus Therapeutics
DNTH
$6.15B
$1.15M ﹤0.01%
51,166
+7,044
+16% +$193K
WHD icon
884
Cactus
WHD
$5.5B
$1.15M ﹤0.01%
30,000
-50,000
-63% -$2M
PDYN icon
885
Palladyne AI
PDYN
$291M
$1.11M ﹤0.01%
83,333
– –
IMRX icon
886
Immuneering
IMRX
$289M
$1.07M ﹤0.01%
75,000
-10,000
-12% -$79.4K
VAPO
887
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$1.02M ﹤0.01%
81,250
– –
ICVX
888
DELISTED
Icosavax, Inc. Common Stock
ICVX
$1.01M ﹤0.01%
320,000
– –
BBIO icon
889
BridgeBio Pharma
BBIO
$16.2B
$994K ﹤0.01%
+100,000
New +$1.04M
ABEO icon
890
Abeona Therapeutics
ABEO
$393M
$974K ﹤0.01%
320,290
-1
-0% -$4
PUMP icon
891
ProPetro Holding
PUMP
$1.34B
$966K ﹤0.01%
120,000
-80,000
-40% -$715K
MTEM
892
DELISTED
Molecular Templates, Inc.
MTEM
$900K ﹤0.01%
80,000
– –
INBX
893
DELISTED
Inhibrx, Inc. Common Stock
INBX
$898K ﹤0.01%
+50,000
New +$901K
ICD
894
DELISTED
Independence Contract Drilling, Inc.
ICD
$861K ﹤0.01%
+286,932
New +$920K
PRDS
895
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$833K ﹤0.01%
450,000
– –
SYRE icon
896
Spyre Therapeutics
SYRE
$9.12B
$789K ﹤0.01%
60,000
– –
MDVL
897
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$776K ﹤0.01%
20,000
– –
PTCT icon
898
PTC Therapeutics
PTCT
$5.91B
$753K ﹤0.01%
15,000
-45,000
-75% -$2.2M
CND.WS
899
DELISTED
Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CND.WS
$749K ﹤0.01%
1,250,026
– –
HCIC
900
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$740K ﹤0.01%
75,000
– –
34 35
36
37 38

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Adage Capital Partners held 1,160 positions worth $40.3B, down 7.6% from $43.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Adage Capital Partners withdrew a net $1.89B in Q3 2022, closing 113 positions and reducing 431 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $101M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Avalara, Inc. worth $153M.

  • Adage Capital Partners's largest Q3 2022 buy was Avalara, Inc.: 1,670,000 shares worth $153M.
  • Adage Capital Partners added most to EOG Resources in Q3 2022, an estimated $128M increase.
  • Adage Capital Partners's biggest Q3 2022 reduction was Royalty Pharma, cutting an estimated $365M.
  • Adage Capital Partners fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $101M.
  • Adage Capital Partners's ten largest holdings make up 21% of its $40.3B portfolio in Q3 2022.
  • Adage Capital Partners opened 85 new positions and closed 113 in Q3 2022.
  • Adage Capital Partners's portfolio value fell 7.6% quarter-over-quarter to $40.3B.

Based on Adage Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.